Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In the pivotal STEP 1 clinical trial, participants who received weekly semaglutide injections lost an average of 14.9% of their body weight over 68 weeks , compared with 2.4% in the placebo group (study in the New England Journal of Medicine )
This delay happens because BPC-157 requires time to trigger changes at the cellular level
The powder may have degraded before reconstitution due to improper storage, high temperature exposure, or moisture infiltration into the sealed vial
No serious adverse events organ failure, severe allergic reactions, or deaths have been reliably documented in the peer-reviewed literature at typical research doses
In Australia, these are not legally available for therapeutic use
